TMSH (TransGlobal Assets) EBIT: $-0.54 Mil (TTM As of Dec. 2011)


What is TransGlobal Assets EBIT?

TransGlobal Assets TMSH EBIT is $-0.54 Mil as of Dec. 2011.

TransGlobal Assets's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2011 was $-0.54 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2011 was $-0.54 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. TransGlobal Assets's annualized ROC % for the quarter that ended in Dec. 2011 was -37.29%. TransGlobal Assets's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2011 was -3,857.14%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. TransGlobal Assets's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2011 was -156.98%.


TransGlobal Assets  (OTCPK:TMSH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

TransGlobal Assets's annualized ROC % for the quarter that ended in Dec. 2011 is calculated as:

ROC % (Q: Dec. 2011 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2010 ) + Invested Capital (Q: Dec. 2011 ))/ count )
=-0.54 * ( 1 - 0% )/( (1.117 + 1.779)/ 2 )
=-0.54/1.448
=-37.29 %

where

Note: The Operating Income data used here is one times the annual (Dec. 2011) data.

2. Joel Greenblatt's definition of Return on Capital:

TransGlobal Assets's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2011 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2011 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2010  Q: Dec. 2011
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.54/( ( (0.014 + max(-0.15, 0)) + (0.014 + max(-0.668, 0)) )/ 2 )
=-0.54/( ( 0.014 + 0.014 )/ 2 )
=-0.54/0.014
=-3,857.14 %

where Working Capital is:

Working Capital(Q: Dec. 2010 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.15 + 0 + 0)
=-0.15

Working Capital(Q: Dec. 2011 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.002) - (0.13 + 0 + 0.54)
=-0.668

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2011) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

TransGlobal Assets's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2011 )
=-0.54/0.344
=-156.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TransGlobal Assets EBIT Related Terms


TransGlobal Assets EBIT Historical Data

* Premium members only.

The historical data trend for TransGlobal Assets's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransGlobal Assets EBIT Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
EBIT
-0.39 -0.44 -0.01 0.00 -0.54

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
EBIT -0.39 -0.44 -0.01 0.00 -0.54

TMSH vs CLDOF: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TransGlobal Assets's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TransGlobal Assets EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TransGlobal Assets's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TransGlobal Assets's EV-to-EBIT falls into.



TransGlobal Assets EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2011 was $-0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-0.54 Mil mean?
TransGlobal Assets (TMSH) has a EBIT of $-0.54 Mil as of Dec. 2011. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on TransGlobal Assets.
Is TransGlobal Assets' EBIT too high?
TransGlobal Assets' current EBIT is $-0.54 Mil.
How does TransGlobal Assets' EBIT compare to CLDOF?
TransGlobal Assets' EBIT of $-0.54 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on TransGlobal Assets. TransGlobal Assets's current EBIT is $-0.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransGlobal Assets stock overvalued right now?
TransGlobal Assets (TMSH) has a current EBIT of $-0.54 Mil. The current EBIT is $-0.54 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For TransGlobal Assets (TMSH), the current EBIT is $-0.54 Mil as of Dec. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransGlobal Assets Business Description

Address No. 14, 5555 Sagamore Avenue, Portsmouth, NH, USA, 03801
TransGlobal Assets Inc through its subsidiary Mindwell Solutions Group LLC (MWSG), the company develops proprietary solutions that harness AI, biometric analysis, and behavioral data to address high-growth markets, including mental health, relationship wellness, performance analytics, and sports/entertainment. and also offers a pioneer in transforming the health and wellness industries through cutting-edge products and services. The products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. The portfolio includes a range- of-products and services, from telemedicine platforms to wellness retreats and natural health remedies.